MedTrace Logo

Anemia and Red Blood Cells Transfusion in Oncological Surgery

NCT04101240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-09-24

No results posted yet for this study

Summary

Oncologic patients experience anemia and anemia is associated with poor prognosis. Transfusion is associated with adverse events, and equipoise remains on the optimal transfusion strategy in oncologic patients in surgical setting. The primary objective of this study is to determine the impact of anemia and red blood cells (RBC) transfusion on post-operative complications and mortality.

Conditions

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Cécile AUBRON, PU PH · Service de Médecine Intensive Réanimation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04101240 on ClinicalTrials.gov